Stenting atherosclerotic renal arteries: time to be less aggressive.
Percutaneous intervention has become very popular for treating atherosclerotic renal artery stenosis, as the use of stents has boosted the rate of technical success and as more cases are being discovered incidentally during angiography of the coronary or other arteries. Yet randomized trials indicate that the procedure does little in terms of controlling blood pressure and may actually harm as many patients as it helps in terms of renal function. Needed are better ways to predict which patients will benefit and better ways to prevent adverse effects such as atheroembolism.
Simon
James F
JF
Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA. simonj2@ccf.org
D000800:Angioplasty, Balloon; D001161:Arteriosclerosis / Q000150:complications* / Q000628:therapy; D018450:Disease Progression; D017700:Embolism, Cholesterol / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000150:complications; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015995:Prevalence; D012078:Renal Artery Obstruction / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D012307:Risk Factors; D015607:Stents
D010975:Platelet Aggregation Inhibitors